GILD

吉利德科學

130.84

+2.00+1.55%
After Hours: 131.64  +0.80  +0.61%19:15 04/30 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE136.50/136.30
TODAY RANGE133.76-136.50
VOL8.90M
MARKET CAP166.40B
52 WEEK RANGE92.83-156.40
AVG VOL (3M)6.39M
% TURNOVER0.72%
TURNOVER--
P/E (TTM)19.77
% RANGE2.00%
EPS(TTM)6.78
P/E(FORWARD)18.99
P/B7.33
BVPS18.29
DIVIDEND3.280
P/S5.65
BETA--
DIV YIELD2.45%
FREE FLOAT MKT CAP166.18B
SHARES OUTSTANDING1.24B
NEXT EARNINGS04/22-04/27
FREE FLOAT1.24B
LOT SIZE1
EX-DATE03/13/2026
Same Industry
Name/Symbol
Change%
Price

吉利德科學

GILD

+1.55%
130.84

麥克森

MCK

-0.14%
814.02

生物基因

BIIB

-2.62%
189.28

安進

AMGN

+2.43%
346.25

沙爾製藥

SHPG

0.00%
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+9.07%
0.0842

新基醫藥

CELG

0.00%
108.24

禮來

LLY

+9.80%
934.60

T

Therapeuticsmd Inc

TXMD

-2.76%
2.052

強生

JNJ

-0.72%
228.19

艾伯維

ABBV

-2.23%
206.60

碩騰

ZTS

-0.70%
114.16

N

Novo-Nordisk A/S

NVO

+5.97%
42.70

百時美施貴寶

BMY

-2.82%
58.88

亞力兄製藥

ALXN

0.00%
182.50

輝瑞製藥

PFE

+1.49%
26.65

賽諾菲

SNY

-1.07%
46.08

S

Sanofi FR

GCVRZ

0.00%
0.8711

諾華製藥

NVS

-0.86%
146.59

如瑞迪博士

RDY

-0.66%
13.64

G

GSK PLC

GSK

+1.96%
52.41

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.